C.M. Bidwell & Associates »

Biosante Pharmaceuticals shares owned by C.M. Bidwell & Associates

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by C.M. Bidwell & Associates from 13F filings

Historical chart of C.M. Bidwell & Associates investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by C.M. Bidwell & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by C.M. Bidwell & Associates

Quarter filed Position value Share count Share price at filing
2023-09-30 $190k 3.3k 58.06
2023-06-30 $35k 655 53.83

More positions owned by C.M. Bidwell & Associates

iShares Russell 1000 Index (IWB)
iShares Russell 2000 Index (IWM)
Vanguard S&p 500 Etf idx (VOO)
Vanguard Total Stock Market ETF (VTI)
iShares Brclys Intrdte Gov/Crt Bd (GVI)
Vanguard Short-Term Bond ETF (BSV)
Ishares Tr core strm usbd (ISTB)
Vanguard Europe Pacific ETF (VEA)
Vanguard Malvern Fds strm infproidx (VTIP)
iShares MSCI ACWI ex US Index Fund (ACWX)
Schwab Strategic Tr 0 (SCHP)
Vanguard Total Bond Market ETF (BND)
Schwab U S Broad Market ETF (SCHB)
Schwab Strategic Tr us lrg cap etf (SCHX)
Dimensional Etf Trust (DFAC)

View all positions for C.M. Bidwell & Associates

Top funds holding Biosante Pharmaceuticals

Vanguard Group
Dimensional Fund Advisors
Global Alpha Capital Management
William Blair Investment Management
Kennedy Capital Management
Jpmorgan Chase & Co
Thompson, Siegel, & Walmsley
Citadel Advisors
Charles Schwab Investment Management
Brandywine Global Investment Management
Bank of New York Mellon
Russell Investments
Assenagon Asset Management
Principal Financial Group
WEDGE Capital Management L

View all funds holding Biosante Pharmaceuticals